Last reviewed · How we verify

Gemigliptin tartrate sesquihydrate and metformin

LG Chem · Phase 1 active Small molecule

Gemigliptin tartrate sesquihydrate and metformin is a Small molecule drug developed by LG Chem. It is currently in Phase 1 development. Also known as: Zemimet® SR Tab. 50/1000 mg.

At a glance

Generic nameGemigliptin tartrate sesquihydrate and metformin
Also known asZemimet® SR Tab. 50/1000 mg
SponsorLG Chem
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Gemigliptin tartrate sesquihydrate and metformin

What is Gemigliptin tartrate sesquihydrate and metformin?

Gemigliptin tartrate sesquihydrate and metformin is a Small molecule drug developed by LG Chem.

Who makes Gemigliptin tartrate sesquihydrate and metformin?

Gemigliptin tartrate sesquihydrate and metformin is developed by LG Chem (see full LG Chem pipeline at /company/lg-chem).

Is Gemigliptin tartrate sesquihydrate and metformin also known as anything else?

Gemigliptin tartrate sesquihydrate and metformin is also known as Zemimet® SR Tab. 50/1000 mg.

What development phase is Gemigliptin tartrate sesquihydrate and metformin in?

Gemigliptin tartrate sesquihydrate and metformin is in Phase 1.

Related